0
     

Report Added
Report already added
Global Nucleic Acid-based Drugs Market Growth (Status and Outlook) 2021-2026

Global Nucleic Acid-based Drugs Market Growth (Status and Outlook) 2021-2026

According to this study, over the next five years the Nucleic Acid-based Drugs market will register a % CAGR in terms of revenue, the global market size will reach $ million by 2026, from $ million in 2020.Specially this report presents the global revenue market share of key companies in Nucleic Acid-based Drugs business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid-based Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by product type:
ASO
mRNA
siRNA
miRNA
saRNA
Aptamer

Segmentation by Application:
Genetic Disease
Cancer
Cardiovascular Diseases
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Ionis Pharmaceuticals
Sarepta Therapeutics
Nippon Shinyaku
BioNTech
Moderna Therapeutics
CureVac
Alnylam Pharmaceuticals
Regulus Therapeutics
Miragen Therapeutics
Mina Therapeutics
NeXstar Pharmaceuticals
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nucleic Acid-based Drugs Market Size 2021-2026
2.1.2 Nucleic Acid-based Drugs Market Size CAGR by Region
2.2 Nucleic Acid-based Drugs Segment by Type
2.2.1 ASO
2.2.2 mRNA
2.2.3 siRNA
2.2.4 miRNA
2.2.5 saRNA
2.2.6 Aptamer
2.3 Nucleic Acid-based Drugs Market Size by Type
2.3.1 Global Nucleic Acid-based Drugs Market Size Market Share by Type (2021-2026)
2.3.2 Global Nucleic Acid-based Drugs Market Size Growth Rate by Type (2021-2026)
2.4 Nucleic Acid-based Drugs Segment by Application
2.4.1 Genetic Disease
2.4.2 Cancer
2.4.3 Cardiovascular Diseases
2.4.4 Other
2.5 Nucleic Acid-based Drugs Market Size by Application
2.5.1 Global Nucleic Acid-based Drugs Market Size Market Share by Application (2021-2026)
2.5.2 Global Nucleic Acid-based Drugs Market Size Growth Rate by Application (2021-2026)

3 Nucleic Acid-based Drugs Key Players
3.1 Date of Key Players Enter into Nucleic Acid-based Drugs
3.2 Key Players Nucleic Acid-based Drugs Product Offered
3.3 Key Players Nucleic Acid-based Drugs Funding/Investment Analysis
3.4 Funding/Investment
3.4.1 Funding/Investment by Regions
3.4.2 Funding/Investment by End-Industry
3.5 Key Players Nucleic Acid-based Drugs Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions

4 Nucleic Acid-based Drugs by Regions
4.1 Nucleic Acid-based Drugs Market Size by Regions (2021-2026)
4.2 Americas Nucleic Acid-based Drugs Market Size Growth (2021-2026)
4.3 APAC Nucleic Acid-based Drugs Market Size Growth (2021-2026)
4.4 Europe Nucleic Acid-based Drugs Market Size Growth (2021-2026)

5 Americas
5.1 Americas Nucleic Acid-based Drugs Market Size by Countries (2021-2026)
5.2 Americas Nucleic Acid-based Drugs Market Size by Type (2021-2026)
5.3 Americas Nucleic Acid-based Drugs Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Nucleic Acid-based Drugs Market Size by Regions
6.2 APAC Nucleic Acid-based Drugs Market Size by Type (2021-2026)
6.3 APAC Nucleic Acid-based Drugs Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Nucleic Acid-based Drugs by Countries (2021-2026)
7.2 Europe Nucleic Acid-based Drugs Market Size by Type (2021-2026)
7.3 Europe Nucleic Acid-based Drugs Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Market Drivers, Challenges and Trends
8.1 Market Drivers and Impact
8.1.1 Growing Demand from Key Regions
8.1.2 Growing Demand from Key Applications and Potential Industries
8.2 Market Challenges and Impact
8.3 Market Trends
8.4 Market Ecosystem and Roles

9 Key Investors in Nucleic Acid-based Drugs
9.1 Company A
9.1.1 Company A Company Details
9.1.2 Company Description
9.1.3 Companies Invested by Company A
9.1.4 Company A Key Development and Market Layout
9.2 Company B
9.2.1 Company B Company Details
9.2.2 Company Description
9.2.3 Companies Invested by Company B
9.2.4 Company B Key Development and Market Layout
9.3 Company C
9.3.1 Company C Company Details
9.3.2 Company Description
9.3.3 Companies Invested by Company C
9.3.4 Company C Key Development and Market Layout
9.4 Company D
9.5 ……

10 Key Players Analysis
10.1 Ionis Pharmaceuticals
10.1.1 Ionis Pharmaceuticals Company Details
10.1.2 Ionis Pharmaceuticals Nucleic Acid-based Drugs Product Offered
10.1.3 Ionis Pharmaceuticals Nucleic Acid-based Drugs Market Size (2021 VS 2026)
10.1.4 Ionis Pharmaceuticals Main Business Overview
10.1.5 Ionis Pharmaceuticals News
10.2 Sarepta Therapeutics
10.2.1 Sarepta Therapeutics Company Details
10.2.2 Sarepta Therapeutics Nucleic Acid-based Drugs Product Offered
10.2.3 Sarepta Therapeutics Nucleic Acid-based Drugs Market Size (2021 VS 2026)
10.2.4 Sarepta Therapeutics Main Business Overview
10.2.5 Sarepta Therapeutics News
10.3 Nippon Shinyaku
10.3.1 Nippon Shinyaku Company Details
10.3.2 Nippon Shinyaku Nucleic Acid-based Drugs Product Offered
10.3.3 Nippon Shinyaku Nucleic Acid-based Drugs Market Size (2021 VS 2026)
10.3.4 Nippon Shinyaku Main Business Overview
10.3.5 Nippon Shinyaku News
10.4 BioNTech
10.4.1 BioNTech Company Details
10.4.2 BioNTech Nucleic Acid-based Drugs Product Offered
10.4.3 BioNTech Nucleic Acid-based Drugs Market Size (2021 VS 2026)
10.4.4 BioNTech Main Business Overview
10.4.5 BioNTech News
10.5 Moderna Therapeutics
10.5.1 Moderna Therapeutics Company Details
10.5.2 Moderna Therapeutics Nucleic Acid-based Drugs Product Offered
10.5.3 Moderna Therapeutics Nucleic Acid-based Drugs Market Size (2021 VS 2026)
10.5.4 Moderna Therapeutics Main Business Overview
10.5.5 Moderna Therapeutics News
10.6 CureVac
10.6.1 CureVac Company Details
10.6.2 CureVac Nucleic Acid-based Drugs Product Offered
10.6.3 CureVac Nucleic Acid-based Drugs Market Size (2021 VS 2026)
10.6.4 CureVac Main Business Overview
10.6.5 CureVac News
10.7 Alnylam Pharmaceuticals
10.7.1 Alnylam Pharmaceuticals Company Details
10.7.2 Alnylam Pharmaceuticals Nucleic Acid-based Drugs Product Offered
10.7.3 Alnylam Pharmaceuticals Nucleic Acid-based Drugs Market Size (2021 VS 2026)
10.7.4 Alnylam Pharmaceuticals Main Business Overview
10.7.5 Alnylam Pharmaceuticals News
10.8 Regulus Therapeutics
10.8.1 Regulus Therapeutics Company Details
10.8.2 Regulus Therapeutics Nucleic Acid-based Drugs Product Offered
10.8.3 Regulus Therapeutics Nucleic Acid-based Drugs Market Size (2021 VS 2026)
10.8.4 Regulus Therapeutics Main Business Overview
10.8.5 Regulus Therapeutics News
10.9 Miragen Therapeutics
10.9.1 Miragen Therapeutics Company Details
10.9.2 Miragen Therapeutics Nucleic Acid-based Drugs Product Offered
10.9.3 Miragen Therapeutics Nucleic Acid-based Drugs Market Size (2021 VS 2026)
10.9.4 Miragen Therapeutics Main Business Overview
10.9.5 Miragen Therapeutics News
10.10 Mina Therapeutics
10.10.1 Mina Therapeutics Company Details
10.10.2 Mina Therapeutics Nucleic Acid-based Drugs Product Offered
10.10.3 Mina Therapeutics Nucleic Acid-based Drugs Market Size (2021 VS 2026)
10.10.4 Mina Therapeutics Main Business Overview
10.10.5 Mina Therapeutics News
10.11 NeXstar Pharmaceuticals

11 Research Findings and Conclusion

List of Tables
Table 1. Nucleic Acid-based Drugs Market Size CAGR by Region (2021-2026) ($ Millions)
Table 2. Major Players of ASO
Table 3. Major Players of mRNA
Table 4. Major Players of siRNA
Table 5. Major Players of miRNA
Table 6. Major Players of saRNA
Table 7. Major Players of Aptamer
Table 8. Global Nucleic Acid-based Drugs Market Size by Type (2021-2026) ($ Millions)
Table 9. Global Nucleic Acid-based Drugs Market Size Market Share by Type (2021-2026)
Table 10. Global Nucleic Acid-based Drugs Market Size by Application (2021-2026) ($ Millions)
Table 11. Global Nucleic Acid-based Drugs Market Size Market Share by Application (2021-2026)
Table 12. Date of Global Key Players Enter into Nucleic Acid-based Drugs Market
Table 13. Global Key Players Nucleic Acid-based Drugs Product Offered
Table 14. Key Players Nucleic Acid-based Drugs Funding/Investment ($ Millions)
Table 15. Funding/Investment by Regions
Table 16. Funding/Investment by End Industry
Table 17. Key Players Nucleic Acid-based Drugs Valuation & Market Capitalization ($ Millions)
Table 18. Key Players Mergers & Acquisitions, Expansion Plans
Table 19. Nucleic Acid-based Drugs New Product/Technology Launches
Table 20. Nucleic Acid-based Drugs Industry Partnerships, Agreements, and Collaborations
Table 21. Nucleic Acid-based Drugs Industry Mergers and Acquisitions
Table 22. Global Nucleic Acid-based Drugs Market Size by Regions 2021-2026 ($ Millions)
Table 23. Global Nucleic Acid-based Drugs Market Size Market Share by Regions 2021-2026
Table 24. Americas Nucleic Acid-based Drugs Market Size by Countries (2021-2026) ($ Millions)
Table 25. Americas Nucleic Acid-based Drugs Market Size Market Share by Countries (2021-2026)
Table 26. Americas Nucleic Acid-based Drugs Market Size by Type (2021-2026) ($ Millions)
Table 27. Americas Nucleic Acid-based Drugs Market Size Market Share by Type (2021-2026)
Table 28. Americas Nucleic Acid-based Drugs Market Size by Application (2021-2026) ($ Millions)
Table 29. Americas Nucleic Acid-based Drugs Market Size Market Share by Application (2021-2026)
Table 30. APAC Nucleic Acid-based Drugs Market Size by Regions (2021-2026) ($ Millions)
Table 31. APAC Nucleic Acid-based Drugs Market Size Market Share by Regions (2021-2026)
Table 32. APAC Nucleic Acid-based Drugs Market Size by Type (2021-2026) ($ Millions)
Table 33. APAC Nucleic Acid-based Drugs Market Size Market Share by Type (2021-2026)
Table 34. APAC Nucleic Acid-based Drugs Market Size by Application (2021-2026) ($ Millions)
Table 35. APAC Nucleic Acid-based Drugs Market Size Market Share by Application (2021-2026)
Table 36. Europe Nucleic Acid-based Drugs Market Size by Countries (2021-2026) ($ Millions)
Table 37. Europe Nucleic Acid-based Drugs Market Size Market Share by Countries (2021-2026)
Table 38. Europe Nucleic Acid-based Drugs Market Size by Type (2021-2026) ($ Millions)
Table 39. Europe Nucleic Acid-based Drugs Market Size Market Share by Type (2021-2026)
Table 40. Europe Nucleic Acid-based Drugs Market Size by Application (2021-2026) ($ Millions)
Table 41. Europe Nucleic Acid-based Drugs Market Size Market Share by Application (2021-2026)
Table 42. Key and Potential Regions of Nucleic Acid-based Drugs
Table 43. Key Application and Potential Industries of Nucleic Acid-based Drugs
Table 44. Key Challenges of Nucleic Acid-based Drugs
Table 45. Key Trends of Nucleic Acid-based Drugs
Table 46. Company A Company Details
Table 47. Companies Invested by Company A
Table 48. Company A Key Development and Market Layout
Table 49. Company B Company Details
Table 50. Companies Invested by Company B
Table 51. Company B Key Development and Market Layout
Table 52. Company C Company Details
Table 53. Companies Invested by Company C
Table 54. Company C Key Development and Market Layout
Table 55. Company C Company Details
Table 56. Companies Invested by Company C
Table 57. Company C Key Development and Market Layout
Table 58. Ionis Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table 59. Ionis Pharmaceuticals Nucleic Acid-based Drugs Market Size (2021 VS 2026)
Table 60. Sarepta Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table 61. Sarepta Therapeutics Nucleic Acid-based Drugs Market Size (2021 VS 2026)
Table 62. Nippon Shinyaku Basic Information, Head Office, Major Market Areas and Its Competitors
Table 63. Nippon Shinyaku Nucleic Acid-based Drugs Market Size (2021 VS 2026)
Table 64. BioNTech Basic Information, Head Office, Major Market Areas and Its Competitors
Table 65. BioNTech Nucleic Acid-based Drugs Market Size (2021 VS 2026)
Table 66. Moderna Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table 67. Moderna Therapeutics Nucleic Acid-based Drugs Market Size (2021 VS 2026)
Table 68. CureVac Basic Information, Head Office, Major Market Areas and Its Competitors
Table 69. CureVac Nucleic Acid-based Drugs Market Size (2021 VS 2026)
Table 70. Alnylam Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table 71. Alnylam Pharmaceuticals Nucleic Acid-based Drugs Market Size (2021 VS 2026)
Table 72. Regulus Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table 73. Regulus Therapeutics Nucleic Acid-based Drugs Market Size (2021 VS 2026)
Table 74. Miragen Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table 75. Miragen Therapeutics Nucleic Acid-based Drugs Market Size (2021 VS 2026)
Table 76. Mina Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table 77. Mina Therapeutics Nucleic Acid-based Drugs Market Size (2021 VS 2026)
Table 78. NeXstar Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table 79. NeXstar Pharmaceuticals Nucleic Acid-based Drugs Market Size (2021 VS 2026)

List of Figures
Figure 1. Picture of Nucleic Acid-based Drugs
Figure 2. Nucleic Acid-based Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nucleic Acid-based Drugs Market Size Growth Rate 2021-2026 ($ Millions)
Figure 7. Nucleic Acid-based Drugs Market Size by Region (2021 & 2026) ($ millions)
Figure 8. Global Nucleic Acid-based Drugs Market Size Market Share by Type (2021-2026)
Figure 9. Global ASO Market Size Growth Rate
Figure 10. Global mRNA Market Size Growth Rate
Figure 11. Global siRNA Market Size Growth Rate
Figure 12. Global miRNA Market Size Growth Rate
Figure 13. Global saRNA Market Size Growth Rate
Figure 14. Global Aptamer Market Size Growth Rate
Figure 15. Nucleic Acid-based Drugs in Genetic Disease
Figure 16. Global Nucleic Acid-based Drugs Market: Genetic Disease (2021-2026) ($ Millions)
Figure 17. Nucleic Acid-based Drugs in Cancer
Figure 18. Global Nucleic Acid-based Drugs Market: Cancer (2021-2026) ($ Millions)
Figure 19. Nucleic Acid-based Drugs in Cardiovascular Diseases
Figure 20. Global Nucleic Acid-based Drugs Market: Cardiovascular Diseases (2021-2026) ($ Millions)
Figure 21. Nucleic Acid-based Drugs in Other
Figure 22. Global Nucleic Acid-based Drugs Market: Other (2021-2026) ($ Millions)
Figure 23. Global Nucleic Acid-based Drugs Market Size Market Share by Application (2021-2026)
Figure 24. Global Nucleic Acid-based Drugs Market Size in Genetic Disease Growth Rate
Figure 25. Global Nucleic Acid-based Drugs Market Size in Cancer Growth Rate
Figure 26. Global Nucleic Acid-based Drugs Market Size in Cardiovascular Diseases Growth Rate
Figure 27. Global Nucleic Acid-based Drugs Market Size in Other Growth Rate
Figure 28. Funding/Investment
Figure 29. Global Nucleic Acid-based Drugs Market Size Market Share by Regions 2021-2026
Figure 30. Americas Nucleic Acid-based Drugs Market Size 2021-2026 ($ Millions)
Figure 31. APAC Nucleic Acid-based Drugs Market Size 2021-2026 ($ Millions)
Figure 32. Europe Nucleic Acid-based Drugs Market Size 2021-2026 ($ Millions)
Figure 33. Americas Nucleic Acid-based Drugs Market Size Market Share by Countries in 2020
Figure 34. Americas Nucleic Acid-based Drugs Market Size Market Share by Type in 2020
Figure 35. Americas Nucleic Acid-based Drugs Market Size Market Share by Application in 2020
Figure 36. United States Nucleic Acid-based Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 37. Canada Nucleic Acid-based Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 38. Mexico Nucleic Acid-based Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 39. Brazil Nucleic Acid-based Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 40. APAC Nucleic Acid-based Drugs Market Size Market Share by Regions in 2020
Figure 41. APAC Nucleic Acid-based Drugs Market Size Market Share by Type in 2020
Figure 42. APAC Nucleic Acid-based Drugs Market Size Market Share by Application in 2020
Figure 43. China Nucleic Acid-based Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 44. Japan Nucleic Acid-based Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 45. Korea Nucleic Acid-based Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 46. Southeast Asia Nucleic Acid-based Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 47. India Nucleic Acid-based Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 48. Australia Nucleic Acid-based Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 49. Europe Nucleic Acid-based Drugs Market Size Market Share by Countries in 2020
Figure 50. Europe Nucleic Acid-based Drugs Market Size Market Share by Type in 2020
Figure 51. Europe Nucleic Acid-based Drugs Market Size Market Share by Application in 2020
Figure 52. Germany Nucleic Acid-based Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 53. France Nucleic Acid-based Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 54. UK Nucleic Acid-based Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 55. Italy Nucleic Acid-based Drugs Market Size Growth 2021-2026 ($ Millions)
Figure 56. Russia Nucleic Acid-based Drugs Market Size Growth 2021-2026 ($ Millions)

Report Title: Global Nucleic Acid-based Drugs Market Growth (Status and Outlook) 2021-2026


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW